Used primarily in pharmaceutical research as a chiral intermediate in the synthesis of nicotinic acetylcholine receptor (nAChR) modulators. It plays a key role in developing compounds targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its stereochemistry enhances binding selectivity to specific receptor subtypes, improving efficacy and reducing side effects in drug candidates. Also employed in the development of novel antidepressants and cognitive enhancers due to its influence on neurotransmitter activity. Commonly found in preclinical studies for central nervous system (CNS) active agents.